SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/254191"
 

Search: onr:"swepub:oai:gup.ub.gu.se/254191" > Tissue Factor promo...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Tissue Factor promotes breast cancer stem cell activity in vitro

Shaker, H. (author)
Harrison, H. (author)
Clarke, R. (author)
show more...
Landberg, Göran, 1963 (author)
Gothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center
Bundred, N. J. (author)
Versteeg, H. H. (author)
Kirwan, C. C. (author)
show less...
 (creator_code:org_t)
2016-12-13
2017
English.
In: Oncotarget. - : Impact Journals, LLC. - 1949-2553. ; 8:16, s. 25915-25927
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Cancer stem cells (CSCs) are a subpopulation of cells that can self-renew and initiate tumours. The clotting-initiating protein Tissue Factor (TF) promotes metastasis and may be overexpressed in cancer cells with increased CSC activity. We sought to determine whether TF promotes breast CSC activity in vitro using human breast cancer cell lines. TF expression was compared in anoikis-resistant (CSC-enriched) and unselected cells. In cells sorted into of TF-expressing and TF-negative (FACS), and in cells transfected to knockdown TF (siRNA) and overexpress TF (cDNA), CSC activity was compared by (i) mammosphere forming efficiency (MFE) (ii) holoclone colony formation (Hc) and (iii) ALDH1 activity. TF expression was increased in anoikis-esistant and high ALDH1-activity T47D cells compared to unselected cells. FACS sorted TF-expressing T47Ds and TF-overexpressing MCF7s had increased CSC activity compared to TF-low cells. TF siRNA cells (MDAMB231, T47D) had reduced CSC activity compared to control cells. FVIIa increased MFE and ALDH1 in a dose-dependent manner (MDAMB231, T47D). The effects of FVIIa on MFE were abrogated by TF siRNA (T47D). Breast CSCs (in vitro) demonstrate increased activity when selected for high TF expression, when induced to overexpress TF, and when stimulated (with FVIIa). Targeting the TF pathway in vivo may abrogate CSC activity.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

cancer stem cells
tissue factor
breast cancer
GROWTH-FACTOR RECEPTOR
FACTOR VIIA
FACTOR EXPRESSION
SIGNALING
PATHWAY
COAGULATION
TUMORIGENICITY
INTERFERENCE
ANGIOGENESIS
ACTIVATION
RESISTANCE

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Oncotarget (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view